CAR-T cell therapy is a relatively new treatment for multiple myeloma. It involves collecting T cells from a person with myeloma, genetically modifying them in a lab, and then returning them to the body to help the immune system fight cancer more effectively.

Experiences with CAR-T cell therapy can vary
- Positive Show Full Answer

CAR-T cell therapy is a relatively new treatment for multiple myeloma. It involves collecting T cells from a person with myeloma, genetically modifying them in a lab, and then returning them to the body to help the immune system fight cancer more effectively.

Experiences with CAR-T cell therapy can vary:
- Positive Outcomes: Many people with hard-to-treat myeloma have seen significant improvements, with some going into remission for at least a year.
- Side Effects: Common side effects include infections, muscle aches, diarrhea, nausea, swelling, fever, cough, headache, and loss of appetite. Most side effects are mild, but some can be serious, such as Cytokine Release Syndrome (CRS).

It's important to discuss potential risks and benefits with your healthcare team. For more personal stories, you can join MyMyelomaTeam, a social network for people with multiple myeloma and their loved ones.

 This AI-generated response comes from MyMyelomaTeam and other selected sources. It is not a substitute for medical advice. Always ask your doctor about specific health concerns.

CAR-T Cell Therapy for Multiple Myeloma: What Is It? | MyMyelomaTeam

Immunotherapy for Multiple Myeloma: What To Know | MyMyelomaTeam